Saturday, March 15, 2008

12:00–6:00 pmMorbidity and Mortality: Learning From OurMistakes (SY)Ballroom AB

Coordinator: Howard Chrisman, MD

To err is human and medicine is a uniquely humanendeavor. Although medical science provides uswith statistics, algorithms and guidelines, much ofan IR physician’s job still relies on intuition andjudgment. In this environment failure, althoughunwanted, is inevitable. M and M is about failure:how it happens, what can be learned from it andhow it can be avoided and overcome in the future.In this half-day symposium, distinguished IR fac-ulty will present a series of clinical case narrativesillustrating how IR complications happen and howthey can be avoided. Fast-paced M and M vignettesessions will be interspersed with didactic presen-tations on evolving approaches to performanceimprovement, peer review, and expert lectures onmedical-legal and quality assurance issues.

Attendees of this symposium will be required tosign a waiver of participation before joining thesession. A copy of this waiver may be obtained onthe SIR Web site at www.SIRweb.org. Forms willalso be available at the meeting, but completion ofthe form in advance will assure quicker entrance tothe session.

Objectives—At the end of this session, thelearner should be able to:

1. Identify critical decision points in the perfor-mance of an IR procedure that increase thelikelihood of an adverse outcome

2. Describe methods to reduce risk during IR pro-cedures

3. Recognize the key components of modernQuality Assurance and Performance Improve-ment programs as well as peer review in IR

Expert Panel: Ziv J Haskal, MD, FSIR, James F.Benenati, MD, FSIR, Albert A. Nemcek, Jr., MD,FSIR, Robert L. Vogelzang, MD, FSIR, William S.Rilling, MD, FSIR

Didactic Speakers: Charles Watts, Albert A. Nem-cek, Jr., MD, FSIR, Andrew H. Cragg, MD, FSIR,Robert L. Vogelzang, MD, FSIR

Case Presenters: James F. Benenati, MD, FSIR, Al-bert A. Nemcek, Jr., MD, FSIR, William S. Rilling,MD, FSIR, Robert L. Vogelzang, MD, FSIR, MichaelD. Darcy, MD, FSIR, Timothy W.I. Clark, MD, FSIR,

Ziv J Haskal, MD, FSIR, Robert K.W. Ryu, MD, FSIR,Scott A. Resnik, MD, John F. Angle, MD

12:00 pmIntroductionHoward B. Chrisman, MD, MBA, FSIR

12:05 pmPsychodynamics of ComplicationsRobert L. Vogelzang, MD, FSIR

12:15 pmCase Presentation

12:45 pmFlying by the seat of your pants or is flying saferthan angioplastyAndrew H. Cragg, MD, FSIR

12:55 pmBreak

1:00 pmCase Presentation

1:30 pmThe Medical Ethics of Medical MalpracticeRobert L. Vogelzang, MD, FSIR

1:40 pmCase Presentation

2:10 pmBreak

2:15 pmQuestion and Answer

2:30 pmCase Presentation

3:00 pmMinimizing risk, Managing lawsuitsCharles Watts

3:25 pmCase Presentation

3:55 pmBreak

4:00 pmQuestion and AnswerPanel

12:00 pm–6:00 pmPAD: Management Strategies forClaudication and Chronic Limb Ischemia(SY)Ballroom C

Coordinator: Mahmood Razavi, MD

This half-day symposium will provide registrantswith a comprehensive guide to the current man-

SATURDAY

P1

agement of peripheral arterial disease. Modernconcepts of disease pathophysiology, natural his-tory and epidemiology will be followed by anin-depth discussion of clinical presentation, symp-tomatology and clinical management. Standardand emerging endovascular treatment strategieswill be described and the evidence basis for treat-ment selection will be presented.

Areas of focus include iliofemoral disease as wellas critical limb ischemia. Controversies in revascu-larization will be the focus of expert debate. Inter-nationally renowned authorities will discuss thelatest technology for PAD treatment and sharestrategies for successful practice building.

Objectives—At the end of this session, thelearner should be able to:

1. Discuss the diagnosis and clinical managementof patients with claudication and critical limbischemia including what the interventionalistshould do and what should be referred

2. Describe the peri-procedural medications forpatients undergoing endovascular interventionsfor claudication and critical limb ischemia

3. Discuss the evidence for the current interven-tions in the lower limb ischemia including thefemoropopliteal and tibial vessels

4. Review the latest trials in the superficial femoraland tibial arteries

12:00 pmPAD: New appreciation of an old diseaseBarry Katzen, MD, FSIR

12:08 pmNatural history & Diagnosis of PADZiv J Haskal, MD, FSIR, FACR, FAHA

12:16 pmManagement of PAD: It begins with exercise &risk factor modificationAlan T. Hirsch, MD

12:24 pmAntiplatelets & anticoagulation: When & howAndrew S. Blum, MD

12:32 pmTASC II Classification of PADAlain T. Drooz, MD

12:40 pmInterventions for aortic occlusive diseaseAlan T. Matsumoto, MD, FSIR

12:48 pmUpdate on the management of iliac arterydiseaseTimothy P. Murphy, MD, FSIR

12:56 pmCommon femoral & profunda: Surgery orendovascular?James F. Benenati, MD, FSIR

1:04 pmThe current tools for SFA interventionsGary Ansel, MD

1:14 pmAn evidence based approach to interventions inSFA: PTA or bare stent?Barry T. Katzen, MD, FSIR

1:22 pmStents in TASC-D SFA disease: Results of aprospective registryMahmood K. Razavi, MD

1:28 pmStent-grafts: A proven technology in SFAGary Ansel, MD

1:36 pmCool-tip laser: A CELLO trial updateDavid A. Allie, MD

1:42 pmContemporary plaque excision: Niche or stand-alone technology for SFA?John E. Aruny, MD

1:50 pmSFA & DES: Where do we stand?Michael D. Dake, MD

1:58 pmUpdate on European trials in SFAJohannes Lammer, MD

2:08 pmBreak

2:30 pmNew innovations in SFA: Motion studies in SFAChris Cheng, PhD

2:38 pmNew innovations in SFA: Why does stent designmatter?Bob Smouse, MD

2:46 pmFuture Technologies in SFABarry T. Katzen, MD, FSIR

2:54 pmDebate: DES is the future in the SFAMichael D. Dake, MD

3:00 pmDebate: Not so fast. There are challengesLindsay Machan, MD, FSIR

P2

3:06 pmSFA Roundtable discussionDavid A. Allie, MD, Gary Ansel, MD, ChrisCheng, PhD, Michael D. Dake, MD, Barry T.Katzen, MD, FSIR, Lindsay Machan, MD, FSIR,Timothy Murphy, MD, FSIR, Bob Smouse, MD

3:21 pmEpidemiology & economic impact of CLIAlan T. Hirsch, MD

3:29 pmClinical presentation & evaluationThomas O. McNamara, MD, FSIR

3:37 pmSurgeon’s perspectiveDavid A. Allie, MD

3:45 pmCLI Interventions: Tools of the tradeMark K. Eskandari, MD

3:53 pmResults of DES and bioabsorbable stents below thekneeJohannes Lammer, MD

4:01 pmDebulking techniques in CLIJohn E. Aruny, MD

4:09 pmResults of cryoplasty and cutting balloons intibialsThomas O. McNamara, MD, FSIR

4:17 pmDebate—CLI is a surgical problemDavid A. Allie, MD

4:23 pmDebate—Not so fast. Endo is better & patientsprefer itMahmood K. Razavi, MD

4:29 pmRound table discussion CLIDavid A. Allie, MD, John E. Aruny, MD, Alan T.Hirsch, MD, Johannes Lammer, MD, Thomas O.McNamara, MD, FSIR, Mahmood K. Razavi, MD

4:40 pmRound table discussion—Proven methodologiesin PAD practice buildingAndrew S. Blum, MD, Alain T. Drooz, MD,Thomas O. McNamara, MD, FSIR, Timothy P.Murphy, MD, FSIR, Mahmood K. Razavi, MD

5:30 pmQuestions and Answers

SATURDAY

P3